The complex of TF and VIIa, as well as the binding of epidermal growth factor to its receptor in cancer cells present in lung cancer, leads to the activation of the mTOR pathway, and the mTOR pathway leads to an increase in the expression of TF in lung cancer and glioblastoma [73]. This evidence concerns the gene TF and lung carcinoma.